Neuphoria Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.37

-0.03 (-0.68%)

As of Jun 30, 10:47 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +238.4% upside

Low Target $9.77

Average Target $14.79

High Target $16.23

Current Price $4.37

Current
$4.37

Target
$14.79

$9.77 $14.79 avg $16.23

Scenario Analysis

Bear Case

$9.77

123.6%

Low target

Base Case

$14.79

+238.4%

Avg target

Bull Case

$16.23

+271.4%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$21.40

-79.6% from high

52-Week Low

$3.65

+19.9% from low

Target vs 52W High

$14.79

-30.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%